DELANDISTROGENE MOXEPARVOVEC-ROKL
Drug approval information sourced from the PBS. Updated nightly from public government registries. Not medical advice.
Access in Australia
- This medicine does not currently appear on the PBS Schedule, according to the Pharmaceutical Benefits Scheme. This can mean a higher out of pocket cost. Your doctor can explain the available access pathways.
- TGA registration data for this medicine is not yet available on Voxsanity.
How it works: Gene Alterations
Drug class: Other drugs for disorders of the musculo-skeletal system
Approval status
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.
Accessing this drug in Australia
This medicine does not currently appear on the PBS Schedule. Your doctor can explain the available access pathways, which may include the TGA Special Access Scheme ↗.
This information is drawn from publicly available PBS records. It is not medical advice. Consult your doctor about access options for your specific situation.
Reported adverse events (FDA database)
These are the reactions most often reported to the FDA's adverse event reporting system in cases where this medicine was recorded as the suspected cause. Reports that list it only as another medicine the person was taking at the time are excluded, because the reaction in those cases was attributed to a different medicine.
- VOMITING — in 37 of 180 such reports
- GAMMA-GLUTAMYLTRANSFERASE INCREASED — in 30 of 180 such reports
- NAUSEA — in 25 of 180 such reports
- ALANINE AMINOTRANSFERASE INCREASED — in 19 of 180 such reports
- TROPONIN I INCREASED — in 18 of 180 such reports
Source: FDA Adverse Event Reporting System (FAERS), openFDA. Counted from a sample of reports in which this medicine was the suspected cause, drawn from 288 reports that mention it in any role. Reporting is voluntary and unverified, so these counts show what gets reported, not how often a reaction occurs, and they cannot be compared between medicines. Discuss any concerns with your doctor.
Approval data sourced from the PBS. Updated nightly. This page does not constitute medical advice. Drug availability and PBS listing status may change. Verify current availability and PBS coverage with your doctor or pharmacist.